Administration of SPT-siRNA at the time of induction of diabetes in Diab and HF-SD groups (Diab/SPT-si and HF-SD/SPT-si groups) prevented activation of Rac1–Nox2 and increase in ROS levels. This evidence concerns the gene AGXT and diabetes mellitus.